Serum-Zn-levels in prostatic cancer.
Zinc in serum of both patients with prostatic carcinoma and men without prostatic cancer was analyzed by flame atomic absorption spectrometry (FAAS). No significant differences were found between the group with prostatic carcinoma without metastasis and the group used for comparison. The Zn level in serum of patients with both prostatic carcinoma and metastases was decreased in comparison to the other groups. A decrease in the Zn concentration was also found for men without metastases after orchiectomy and hormone therapy.
Feustel
A
A
Department of Urology, Markkleeberg Hospital, Leipzig, German Democratic Republic.
Wennrich
R
R
Schmidt
B
B
D000230:Adenocarcinoma / Q000097:blood*; D000368:Aged; D002277:Carcinoma / Q000097:blood*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000097:blood*; D015032:Zinc / Q000097:blood*
D015032:Zinc